
    
      - A Prospective, Randomized, Double-Blind, Placebo-Controlled, Phase III, Multicenter Trial
      to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a
      Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted
      (CAIV-T) in Healthy Children
    
  